-
CancelDate：2024-12
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=860Xiaoyu Bot, the first robotics company in the Xiaomi ecosystem to leverage large model technology, recently announced the closing of its Series A financing, raising 100 million RMB. The round was exclusively funded by the Beijing Information Industry Deve
-
CancelDate：2024-10
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=854Recently, Dingzhi Dental, a leading brand and expert in complex dental implants in China, announced the closing of its Series A financing, raising several hundred million RMB, with Eight Roads as the sole investor. CEC Capital served as the exclusive
-
CancelDate：2024-10
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=848Wuhan-based iRegene, which aims to become a global leader in universal chemically induced cell therapy, recently announced the closing of its Series B financing, raising several hundred million RMB. The round was co-led by Orinno Capital and CDBT Group, w
-
CancelDate：2024-08
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=842MicroCyto announced that it has raised over 300 million yuan in Series A financing. The round was led by Beijing Jingguorui Investment, with participation from Beijing Medical and Health Industry Investment Fund, Shenzhen Capital Group, and Hebei Producti
-
CancelDate：2024-07
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=839MoonBiotech announced that it has recently completed a RMB 300 million Series C+ financing, solely invested by SDIC JULI Investment Management Co., LTD. This financing round follows the Series C funding involving SDIC Venture Capital, marking another inst
-
CancelDate：2024-05
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=775Recently, Blue Sail Medical (002382.SZ) announced that its cardiovascular and cerebrovascular business unit, Blue Sail Biosensors, has raised a total of RMB 1 billion in funding. The Series A2 round introduced an additional RMB 100 million, following a RM
-
Cancel -
CancelDate：2024-05
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=773Recently, Vision Medicals announced a successful completion of D+ round funding worth hundreds of millions RMB, with Kequan Fund as lead-investor and Tianxin Fund as co-investor. Funds raised in this round will be primarily used to promote the research an
-
Cancel
Scan to log in to WeChatLog in on phone to use WeChat on Web
京公網安備 11010102004518號